Geographical Group Reporting Submission

Cochrane US (American College of Physicians)
Kate Carroll
Living Clinical Guideline and Living Systematic Review and Network Meta-Analysis on Treatments for Adults with Major Depressive Disorder
Which function does this relate to?
Promote Cochrane and its work
N/A
N/A
N/A
Other review and evidence production
The American College of Physicians (ACP) funded the development of a living systematic review and network meta-analysis and 2 rapid reviews to develop living, rapid practice points on pharmacologic and nonpharmacologic treatments for adults with major depressive disorder. The evidence reviews were conducted by Cochrane Austria and utilized Cochrane methods and tools.
Date
07-09-2020
Yes
The clinical guideline and systematic review are being maintained as living documents.
Cochrane Austria
Yes
ACP Center for Evidence Reviews at Cochrane Austria/University for Continuing Education Krems (Danube University Krems)
Kate Carroll
kcarroll@acponline.org
Evidence production, Dissemination / Knowledge Translation, Written report or publication
The clinical guideline and evidence reviews were published in Annals of Internal Medicine. The most recent (2022) Impact Factor for Annals of Internal Medicine is 39.2 (Clarivate Analytics). Annals is the most cited general internal medicine journal and one of the most influential journals in the world.

The clinical guideline and systematic review, respectively, have Altmetric Attention Scores of 311 (99th percentile compared to outputs of similar age) and 15 (89th percentile compared to outputs of similar age).

Link to systematic review and network meta-analysis: https://www.acpjournals.org/doi/10.7326/M22-1845

Link to rapid review on values and preferences of patients with depressive disorder: https://www.acpjournals.org/doi/10.7326/M22-1900

Link to rapid review on cost-effectiveness of treatment strategies for major depressive disorder: https://www.acpjournals.org/doi/10.7326/m22-1872